Aviva T. Horowitz

3.1k total citations
29 papers, 2.6k citations indexed

About

Aviva T. Horowitz is a scholar working on Molecular Biology, Biomaterials and Oncology. According to data from OpenAlex, Aviva T. Horowitz has authored 29 papers receiving a total of 2.6k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 13 papers in Biomaterials and 9 papers in Oncology. Recurrent topics in Aviva T. Horowitz's work include Nanoparticle-Based Drug Delivery (13 papers), RNA Interference and Gene Delivery (6 papers) and Glycosylation and Glycoproteins Research (4 papers). Aviva T. Horowitz is often cited by papers focused on Nanoparticle-Based Drug Delivery (13 papers), RNA Interference and Gene Delivery (6 papers) and Glycosylation and Glycoproteins Research (4 papers). Aviva T. Horowitz collaborates with scholars based in Israel, United States and Spain. Aviva T. Horowitz's co-authors include Alberto Gabizón, Dorit Goren, Samuel Zalipsky, Dinah Tzemach, Dina Tzemach, Tali Siegal, Alberto Gabizon, Hilary Shmeeda, Frederika Mandelbaum-Shavit and Dan Gibson and has published in prestigious journals such as Nature, Cancer and Advanced Drug Delivery Reviews.

In The Last Decade

Aviva T. Horowitz

29 papers receiving 2.5k citations

Peers

Countries citing papers authored by Aviva T. Horowitz

Since Specialization

Citations

This map shows the geographic impact of Aviva T. Horowitz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Aviva T. Horowitz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Aviva T. Horowitz more than expected).

Fields of papers citing papers by Aviva T. Horowitz

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Aviva T. Horowitz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Aviva T. Horowitz. The network helps show where Aviva T. Horowitz may publish in the future.

Co-authorship network of co-authors of Aviva T. Horowitz

This figure shows the co-authorship network connecting the top 25 collaborators of Aviva T. Horowitz. A scholar is included among the top collaborators of Aviva T. Horowitz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Aviva T. Horowitz. Aviva T. Horowitz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Nuclear Localization Signal-Targeted Poly(ethylene glycol) Conjugates as Potential Carriers and Nuclear Localizing Agents for Carboplatin Analogues 2004 ·Bioconjugate Chemistry ·(unknown), Aviva T. Horowitz, Alberto Gabizon, Miguel A. Fuertes, (unknown), Dan Gibson	49
2	Folate-Targeted PEG as a Potential Carrier for Carboplatin Analogs. Synthesis and in Vitro Studies 2003 ·Bioconjugate Chemistry ·(unknown), Aviva T. Horowitz, Alberto Gabizon, Dan Gibson	175
3	Folate receptor targeting of pegylated liposomal cisplatin enhances anti-tumor activity in mouse models without increasing toxicity 2002 ·Alberto Gabizón, Aviva T. Horowitz, Dinah Tzemach, Lidia Mak, Samuel Zalipsky, R.M. Abra	2
4	Dose Dependency of Pharmacokinetics and Therapeutic Efficacy of Pegylated Liposomal Doxorubicin (DOXIL) in Murine Models 2002 ·Journal of drug targeting ·Alberto Gabizón, Dinah Tzemach, Lidia Mak, (unknown), Aviva T. Horowitz	128
5	Nuclear delivery of doxorubicin via folate-targeted liposomes with bypass of multidrug-resistance efflux pump. 2000 ·PubMed ·Dorit Goren, Aviva T. Horowitz, Dina Tzemach, (unknown), Samuel Zalipsky, Alberto Gabizón	332
6	Pharmacological studies of cisplatin encapsulated in long-circulating liposomes in mouse tumor models 1999 ·Anti-Cancer Drugs ·(unknown), Dorit Goren, Aviva T. Horowitz, Dina Tzemach, Alberto Gabizon	120
7	Diagnostic value of AgNOR staining in thyroid cytology. 1998 ·PubMed ·(unknown), Rumelia Koren, Aviva T. Horowitz, (unknown), Marisa Halpern, (unknown)	7
8	Comparative study of the antitumor activity of free doxorubicin and polyethylene glycol-coated liposomal doxorubicin in a mouse lymphoma model. 1998 ·PubMed ·Anna Cabanes, Dina Tzemach, Dorit Goren, Aviva T. Horowitz, Alberto Gabizón	60
9	Long-circulating liposomes for drug delivery in cancer therapy: a review of biodistribution studies in tumor-bearing animals 1997 ·Advanced Drug Delivery Reviews ·Alberto Gabizón, Dorit Goren, Aviva T. Horowitz, Dinah Tzemach, Alexander Lossos, Tali Siegal	190
10	Liposome Longevity and Stability in Circulation: Effects on the in vivo Delivery to Tumors and Therapeutic Efficacy of Encapsulated Anthracyclines 1996 ·Journal of drug targeting ·Alberto Gabizón, (unknown), Dinah Tzemach, Aviva T. Horowitz, Dorit Goren	81
11	Targeting of stealth liposomes to erbB-2 (Her/2) receptor: in vitro and in vivo studies 1996 ·British Journal of Cancer ·Dorit Goren, Aviva T. Horowitz, Samuel Zalipsky, Martin C. Woodle, Yosef Yarden, Alberto Gabizón	146
12	Doxorubicin encapsulated in sterically stabilized liposomes for the treatment of a brain tumor model: biodistribution and therapeutic efficacy 1995 ·Journal of neurosurgery ·Tali Siegal, Aviva T. Horowitz, Alberto Gabizón	190
13	Preclinical Studies with Doxorubicin Encapsulated in Polyethyleneglycol-Coated Liposomes 1993 ·Journal of Liposome Research ·Alberto Gabizón, Orit Pappo, Dorit Goren, (unknown), Dinah Tzemach, Aviva T. Horowitz	25
14	In vitro cytotoxicity of liposome-encapsulated doxorubicin: dependence on liposome composition and drug release 1992 ·Biochimica et Biophysica Acta (BBA) - Biomembranes ·Aviva T. Horowitz, Yechezkel Barenholz, Alberto Gabizón	125
15	Maintenance on extracellular matrix and expression of heparanase activity by human ovarian carcinoma cells from biopsy specimens 1990 ·International Journal of Cancer ·Tamar Peretz, (unknown), Uziel Beller, Aviva T. Horowitz, Zvi Fuks, Israël Vlodavsky	10
16	Oncogenous osteomalacia: a case study 1989 ·Bone and Mineral ·D.W. Nitzan, Aviva T. Horowitz, David Darmon, Michael M. Friedlaender, Dvora Rubinger, (unknown), Itai Bab, Mordecai M. Popovtzer, Justin Silver	23
17	Prevention of Human Bladder Tumor Cell Implantation in an in Vitro Assay 1987 ·The Journal of Urology ·(unknown), Aviva T. Horowitz, Israël Vlodavsky, (unknown), S Biran	10
18	Growth of human mammary carcinoma cells from biopsy specimens in serum‐free medium on extracellular matrix 1986 ·International Journal of Cancer ·S Biran, Israël Vlodavsky, Zvi Fuks, G Lijovetzky, Aviva T. Horowitz	8
19	High‐density lipoprotein and extracellular matrix promotes growth and plating efficiency of normal human mammary epithelial cells in serum‐free medium 1983 ·International Journal of Cancer ·S Biran, Aviva T. Horowitz, Zvi Fuks, Israël Vlodavsky	31
20	The Use of Carcinoembryonic Antigen for Identification of Human Tumor Cells in Malignant Effusions 1983 ·Oncology ·Aviva T. Horowitz, Zvi Fuks, Elimelech Okon, S Biran, Abraham J. Treves	2

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact